SS
0
Active Trials
0
Total Trials
0
Organizations
0
Events
South Sudan
Clinical Trials Only
Reimbursed Care Access
South Sudan does not have a formal, publicly documented national program to reimburse or broadly authorize psychedelic-assisted therapies. Ketamine is used in clinical practice as an essential anaesthetic agent, but novel psychedelic medicines (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, mescaline, 2C‑X, and regulated esketamine products) have no evidence of national approval or reimbursement pathways and would only be accessible through approved research or exceptional importation/clinical‑trial arrangements.
No clinical trials found for this country yet.